Cambridge Investment Research Advisors, Inc.
Position in LLY — ELI LILLY & Co
CIK 1419186
FAIRFIELD, IA
Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$218,071,984
+$58,504,766 QoQ
Shares Held
181,813
+4.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#253
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. LLY ranks #1 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
144,124 | $18,208,626 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,071,984 | 181,813 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $159,567,218 | 173,486 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $186,966,395 | 173,974 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $134,929,683 | 176,841 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $132,241,807 | 169,643 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $134,819,070 | 163,237 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $122,904,716 | 159,203 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $146,033,033 | 164,834 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $151,994,289 | 167,879 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $128,700,256 | 165,433 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $94,359,592 | 161,874 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $88,979,881 | 165,658 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $81,309,407 | 173,375 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $52,482,818 | 152,824 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $52,927,902 | 144,675 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $44,525,295 | 137,700 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $40,805,642 | 125,854 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $36,374,431 | 127,019 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $29,536,204 | 106,930 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $23,513,034 | 101,766 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $23,766,336 | 103,548 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $20,054,379 | 107,346 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $17,441,172 | 103,300 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $15,654,003 | 105,756 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $16,490,567 | 100,442 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $13,495,930 | 97,289 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||